Results 181 to 190 of about 38,544 (277)

Clinical trial of raltegravir, an integrase inhibitor, in HAM/TSP. [PDF]

Ann Clin Transl Neurol, 2021
Enose-Akahata Y, Billioux BJ, Azodi S, Dwyer J, Vellucci A, Ngouth N, Nozuma S, Massoud R, Cortese I, Ohayon J, Jacobson S.   +10 more
europepmc   +1 more source

Fragment-Based Discovery of 8-Hydroxyquinoline Inhibitors of the HIV-1 Integrase–Lens Epithelium-Derived Growth Factor/p75 (IN–LEDGF/p75) Interaction

, 2013
Erik Serrao, Bikash Debnath, Hiroyuki Otake, Yuting Kuang, Frauke Christ, Zeger Debyser, Nouri Neamati   +6 more
openalex   +2 more sources

Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort

, 2022
Ramón Teira, Helena Díaz-Cuervo, Filipa Aragão, Manuel Castaño, Alberto Romero-Palacios, Bernardino Roca, Marta Montero, Marı́a José Galindo, Maria Jose Muñoz-Sánchez, Núria Espinosa, Joaquim Peraire, Elisa Martínez, Belén de la Fuente, Peré Domingo, Elisabeth Deig, María Dolores Merino, Paloma Geijo, Vicente Estrada, María Antonia Sepúlveda, Josefina García, Juan Berenguer, Adrián Curran   +21 more
openalex   +1 more source

Interactive effects of morphine and the HIV integrase inhibitor, cabotegravir, in male and female mice. [PDF]

Biomed Pharmacother
Carbajal C, Owens F, Stone N, Swickley J, Jordan M, Tose LV, Fernandez-Lima F, Nefzi A, Buch S, Rodriguez M, El-Hage N.   +10 more
europepmc   +1 more source

A Substituted Indole Scaffold as a Class of Allosteric HIV-1 Integrase Inhibitor

, 2019
Ross H. Bockbrader
openalex   +1 more source

Assessing weight change in adolescents and young adults with perinatally acquired HIV and integrase inhibitor use. [PDF]

HIV Med
Pincus KJ, Faridi N, Ryscavage PA, Seung H, Parbuoni KA, Grant M, Pandit NS.   +6 more
europepmc   +1 more source

Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE). [PDF]

Clin Infect Dis, 2023
Kileel EM, Malvestutto CD, Lo J, Fitch KV, Fichtenbaum CJ, Aberg JA, Zanni MV, Martinez E, Okeke NL, Kumar P, Joao E, Bares SH, Berrner D, Smieja M, Roa JC, McCallum S, Douglas PS, Ribaudo HJ, Grinspoon SK.   +18 more
europepmc   +1 more source

Preswitch Regimens Associated With Weight Gain Among Persons With HIV who Switch to Integrase Inhibitor-Containing Regimens. [PDF]

Open Forum Infect Dis
Cutshaw MK, Harding M, Davenport CA, Okeke NL.   +3 more
europepmc   +1 more source

Virologic outcomes among adults with HIV using integrase inhibitor-based antiretroviral therapy. [PDF]

AIDS, 2022
Lu H, Cole SR, Westreich D, Hudgens MG, Adimora AA, Althoff KN, Silverberg MJ, Buchacz K, Li J, Edwards JK, Rebeiro PF, Lima VD, Marconi VC, Sterling TR, Horberg MA, Gill MJ, Kitahata MM, Eron JJ, Moore RD, North American AIDS Cohort Collaboration on Research, Design of the International Epidemiologic Databases to Evaluate AIDS .   +20 more
europepmc   +1 more source

Exploring Zinc C295 as a Dual HIV-1 Integrase Inhibitor: From Strand Transfer to 3'-Processing Suppression. [PDF]

Pharmaceuticals (Basel)
Sayyed SK, Quraishi M, Prabakaran DS, Chandrasekaran B, Ramesh T, Rajasekharan SK, Raorane CJ, Sonawane T, Ravichandran V.   +8 more
europepmc   +1 more source